1. Home
  2. GYRE vs LEGH Comparison

GYRE vs LEGH Comparison

Compare GYRE & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gyre Therapeutics Inc.

GYRE

Gyre Therapeutics Inc.

HOLD

Current Price

$6.08

Market Cap

624.9M

Sector

Health Care

ML Signal

HOLD

LEGH

Legacy Housing Corporation (TX)

HOLD

Current Price

$22.93

Market Cap

528.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GYRE
LEGH
Founded
2002
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
624.9M
528.7M
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
GYRE
LEGH
Price
$6.08
$22.93
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$17.00
$25.00
AVG Volume (30 Days)
66.5K
67.7K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.46
Revenue
$275,000.00
$164,567,000.00
Revenue This Year
$19.88
$11.90
Revenue Next Year
N/A
$6.58
P/E Ratio
N/A
$49.80
Revenue Growth
N/A
N/A
52 Week Low
$5.97
$18.29
52 Week High
$11.61
$29.45

Technical Indicators

Market Signals
Indicator
GYRE
LEGH
Relative Strength Index (RSI) 32.71 58.79
Support Level N/A $20.53
Resistance Level $8.26 $24.00
Average True Range (ATR) 0.38 0.94
MACD -0.15 0.06
Stochastic Oscillator 4.01 76.49

Price Performance

Historical Comparison
GYRE
LEGH

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sells, and finances manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores, and are also sold directly to manufactured home communities. The Company manufactures and provides for the transport of manufactured homes, provides wholesale financing to dealers and mobile home parks, provides retail financing to consumers, and is involved in financing and developing new manufactured home communities. The Company manufactures its mobile homes at plants in Fort Worth, Texas; Commerce, Texas; and Eatonton, Georgia. The Company also sells homes directly to consumers, through its own retail stores, and to dealers and mobile home parks.

Share on Social Networks: